Circadian Rhythm Sleep Treatment Market Growing at 4.7% CAGR to Touch US$ 1.23 Billion Valuation by 2034: Fact.MR Report

The global circadian rhythm sleep treatment market, valued at USD 784.7 million in 2024, is projected to grow at a CAGR of 4.7% during the period 2024-2034. Products and therapies designed to treat sleep disorders or irregularities associated with circadian rhythm disorders lead the taurotherapy market.

𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9675

Circadian rhythm disorders occur when the body's internal clock determines when it is time to wake up and go. sleep, not in sync with the environment. An internal clock that repeats itself every 24 hours is called a circadian clock. Circadian rhythms are 24-hour cycles that act as the body's internal clock and act as a backdrop for important functions and processes. The market serves conditions such as sleep apnea, arrhythmias and other cardiovascular problems that affect sleep by combining aspects of cardiology and sleep medicine.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

The global bull therapy market is estimated to be valued at US$ 784.7 billion in 2024.
The demand for bull therapy is expected to grow at a 4.7% CAGR between 2024 and 2034.
The market value is forecast to reach US$ 1.23 billion by the end of 2034.
North America is estimated to account for 34.9% of the global market in 2024.
The demand for drugs used in the treatment of circadian rhythms will grow by 4.8% between 2024 and 2034.
The North America market is projected to grow at a CAGR of 4.9% by 2034.
The East Asian market is projected to grow at a CAGR of 5.6% from 2024 to 2034.

"The global market for circadian rhythm sleep treatment is being driven by the rising prevalence of psychological issues such as anxiety, depression, hypertension, and other ailments associated with lack of sleep. Major factors contributing to circadian rhythm sleep disorder include the aging of the population and the increasing incidence of sedentary lifestyle disorders, particularly diabetes," says a Fact.MR analyst.

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝 𝐢𝐧 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭

Vanda Pharmaceuticals, Inc.
Akeda Pharmaceutical Company
LimitedIdorsia Pharmaceuticals Ltd.
VU University Medical
CenterNeuraxpharm
The Sunbox Company

Increasing Prevalence of CRSDs and Technological Advancements in Chronobiology

Circadian sleep disorders (CRSD) are a group of disorders that disrupt the body's natural sleep-wake cycle. Several variables such as jet lag, shift work, and increased exposure to artificial light contribute to the prevalence of CRSDs worldwide. This increases the demand for advanced and improved solutions for the diagnosis and treatment of CRSD.

The circadian rhythm sleep therapy market has undergone radical changes due to technological advances in chronobiology and sleep science. Precision methods are increasingly used to regulate and synchronize disturbed sleep-wake cycles. These strategies range from technological personal therapy to adapted therapy that addresses the challenges of change work. Wearable technologies and digital therapies are ushering in a new era of targeted tactics for improving sleep health and improved diagnosis and treatment of CRSD.

For example, in December 2020, Vanda Pharmaceutical announced that the US FDA approved HETLIOZ liquid and capsule. dosage forms for the diagnosis of Smith-Magenis syndrome (SMS) in adults and children. It is a developmental disorder that disrupts sleep.

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9675

𝐌𝐨𝐫𝐞 𝐕𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐨𝐧 𝐎𝐟𝐟𝐞𝐫

In its new offering, Fact.MR presents an unbiased analysis of the circadian rhythm treatment market for the period 2018-2023 and forecast statistics for the period 2024-2034.

The study highlights key market insights based on treatment (devices, drugs). , chronotherapy). ), disorder (delayed sleep phase syndrome, advanced sleep phase syndrome, non-24-hour sleep-wake syndrome, irregular sleep-wake disorder, shift-shift disorder, jet lag) and sales channel (plant sales, retail) in six major regions of the world (North America, Latin America, Europe, East Asia, South Asia and Oceania and MEA).

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.